Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

McDonald’s Corporation (MCD), Novo Nordisk A/S (ADR) (NVO), Colgate-Palmolive Company (CL): A Look At Jim Simons’ Top Picks for the Second Quarter

Another major hedge fund that recently disclosed its long equity positions for the second quarter of 2014 is Jim Simons’ Renaissance Technologies, one of the best performing firms in the sector. The fund acknowledged holding an equity portfolio with a market value of more than $42.8 billion, after starting 453 new positions and selling out of another 494 over the quarter. Let’s, thus, take a look at its top holdings in order to elucidate if any of them deserve further research.

The first two companies in the fund’s list remained unchanged in rank over the period, although the largest stake placed in McDonald’s Corporation (NYSE:MCD) saw the fund trim its exposure by 2%. Renaissance Technologies now owns 8.29 million shares, down from 8.52 million shares by the end of the first quarter. The fund’s position in McDonald’s Corporation (NYSE:MCD) is worth more than $835 million, and accounts for almost 2% of its equity portfolio’s total value.

RENAISSANCE TECHNOLOGIES

This $91.8 billion market cap fast food restaurant operator saw its stock price inch almost 4% between April and June. However, the stock fell 7.8% ever since, and now trades at only 17 times the company’s earnings –versus an industry average of 28x P/E.

Other major hedge funds betting on McDonald’s Corporation (NYSE:MCD) are Harris Associates, which owns 3.89 million shares of the company, up 4% over the quarter, and Jean-Marie Eveillard’s First Eagle Investment Management, which started a position, with 3.61 million shares, over second the quarter of 2014.

Novo Nordisk A/S (ADR) (NYSE:NVO) also kept its spot in Mr. Simons’ list. The $189 billion market cap healthcare company witnessed a 5% boost in the fund’s exposure between April and June. Renaissance Technologies declared ownership 16.95 million shares of Novo Nordisk A/S (ADR) (NYSE:NVO), worth more than $783 million. However, following a 2:1 split in late-June, the fund’s holdings are now worth approximately $1.5 billion.

Another investor of the company is Ken Fisher’s Fisher Asset Management, which revealed a slight increase in its stake in Novo Nordisk A/S (ADR) (NYSE:NVO) for the second quarter of the year. Recently, the fund made known its 13.74 million shares position in the company.

Finally, there’s Colgate-Palmolive Company (NYSE:CL), a $58.6 billion market cap global consumer products company that escalated from the sixth position in Mr. Simons’ first quarter portfolio. Following a 30% boost in its stake, the fund holds 9.6 million shares of Colgate-Palmolive Company (NYSE:CL), worth approximately $655 million.

Once again, Renaissance Technologies is among the largest hedge fund shareholders of record, followed by Jean-Marie Eveillard’s First Eagle Investment Management. This last fund owns 4.71 million shares of Colgate-Palmolive Company (NYSE:CL), worth about $321 million. In addition, both these funds have been – and will continue to- benefiting from a $0.36 per share quarterly dividend, which implies a 2.2% yield.

Disclosure: Javier Hasse holds no position in any stocks or funds mentioned

Loading Comments...